-
1
المؤلفون: Diego Cecchini, Analía Urueña, Jamile Ballivian, Mara Huberman, Isabel Cassetti, Fernanda Rombini
المصدر: Revista Española de Quimioterapia
مصطلحات موضوعية: Microbiology (medical), medicine.medical_specialty, Darunavir+Ritonavir, Anti-HIV Agents, antiretroviral therapy, Fixed-dose combination, Argentina, Human immunodeficiency virus (HIV), HIV Infections, medicine.disease_cause, Raltegravir Potassium, terapia antiretroviral, Humans, Medicine, Dual therapy, Infección por VIH, Darunavir, Retrospective Studies, Pharmacology, Gynecology, Ritonavir, business.industry, Brief Report, terapia dual, HIV Protease Inhibitors, dual therapy, General Medicine, Viral Load, HIV infection, Raltegravir, business, Viral load, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90ce1f0c9ebd506d9aca20985b5a0cc5Test
https://doi.org/10.37201/req/090.2020Test -
2
المؤلفون: Giselle Ibette Silva Lopez Lopes, Ariane Melaré Ramos dos Santos, Érique José Farias Peixoto de Miranda, Denise Juliato, Amaury Pachione Martins, Luís Fernando de Macedo Brígido, José E. Vidal
المصدر: International Journal of STD & AIDS. 31:967-975
مصطلحات موضوعية: Adult, Male, Pediatrics, medicine.medical_specialty, Darunavir+Ritonavir, Anti-HIV Agents, Human immunodeficiency virus (HIV), Salvage therapy, HIV Infections, Dermatology, medicine.disease_cause, HIV Long-Term Survivors, 03 medical and health sciences, 0302 clinical medicine, Acquired immunodeficiency syndrome (AIDS), Antiretroviral Therapy, Highly Active, medicine, Humans, Pharmacology (medical), 030212 general & internal medicine, Darunavir, Retrospective Studies, Salvage Therapy, 0303 health sciences, Ritonavir, 030306 microbiology, business.industry, Public Health, Environmental and Occupational Health, HIV Protease Inhibitors, Middle Aged, Viral Load, medicine.disease, CD4 Lymphocyte Count, Treatment Outcome, Infectious Diseases, HIV-1, RNA, Viral, Drug Therapy, Combination, Female, business, Brazil, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0bc3c2a25fe94b9f913fc7367cbfabdfTest
https://doi.org/10.1177/0956462420933716Test -
3
المؤلفون: Núria Pérez-Álvarez, Bonaventura Clotet, Mario F Ampuero, Pablo Pelaez, Roger Paredes, Adrian Curran, José R. Santos, José Moltó, Jordi Navarro-Mercade
المصدر: AIDS Research and Human Retroviruses
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instnameمصطلحات موضوعية: Adult, Male, 0301 basic medicine, Oncology, medicine.medical_specialty, Darunavir+Ritonavir, Anti-HIV Agents, Darunavir/Cobicistat, Immunology, HIV Infections, PI monotherapy, DRV/r, 03 medical and health sciences, 0302 clinical medicine, Virology, Internal medicine, Antiretroviral treatment, medicine, Humans, Routine clinical practice, Treatment Failure, 030212 general & internal medicine, Practice Patterns, Physicians', Darunavir, Retrospective Studies, DRV/c, Ritonavir, Drug Substitution, business.industry, Cobicistat, HIV Protease Inhibitors, Middle Aged, Viral Load, routine clinical practice, 030104 developmental biology, Infectious Diseases, HIV-1, RNA, Viral, Female, simplification strategy, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d507356c0f2b337d2e92d7d322c450b9Test
https://doi.org/10.1089/aid.2018.0178Test -
4
المؤلفون: C. Abeli, Giuseppe Bruno, Marco Annovazzi Lodi, Valentina Di Cristo, Maria Vittoria Cossu, Paolo Maggi, Maria Letizia Oreni, Paola Vitiello, Elisa Colella, Anna Volpe, Fulvio Adorni, Stefano Bonora, Stefano Rusconi, Renato Maserati, Micol Ferrara
المصدر: HIV Research & Clinical Practice (Online) 21 (2020): 34–43. doi:10.1080/25787489.2020.1734752
info:cnr-pdr/source/autori:Di Cristo, Valentina; Adorni, Fulvio; Maserati, Renato; Annovazzi Lodi, Marco; Bruno, Giuseppe; Maggi, Paolo; Volpe, Anna; Vitiello, Paola; Abeli, Clara; Bonora, Stefano; Ferrara, Micol; Cossu, Maria Vittoria; Oreni, Maria Letizia; Colella, Elisa; Rusconi, Stefano/titolo:96-week results of a dual therapy with darunavir%2Fritonavir plus rilpivirine once a day vs triple therapy in patients with suppressed viraemia: virological success and non-HIV related morbidity evaluation/doi:10.1080%2F25787489.2020.1734752/rivista:HIV Research & Clinical Practice (Online)/anno:2020/pagina_da:34/pagina_a:43/intervallo_pagine:34–43/volume:21مصطلحات موضوعية: Oncology, endocrine system, medicine.medical_specialty, Dual therapy, Darunavir+Ritonavir, Immunovirological success, business.industry, Rilpivirine, Limiting, chemistry.chemical_compound, Infectious Diseases, chemistry, Internal medicine, Toxicity, medicine, HIV-1, Pharmacology (medical), In patient, Safety, business, Darunavir, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f0a39b3ce2abd113370749595ae77ec3Test
https://publications.cnr.it/doc/426233Test -
5
المؤلفون: Michel Moutschen, Linos Vandekerckhove, Rémy Demeester, Eric Van Wijngaerden, Eric Florence, Jean-Christophe Goffard, Hilde Piryns, Pushpike Thilakarathne, Bernard Vandercam, Stéphane De Wit
المصدر: Acta Clinica Belgica. :1-7
مصطلحات موضوعية: Adult, Male, 0301 basic medicine, Pediatrics, medicine.medical_specialty, Darunavir+Ritonavir, Anti-HIV Agents, 030106 microbiology, HIV Infections, 03 medical and health sciences, 0302 clinical medicine, Belgium, immune system diseases, Antiretroviral Therapy, Highly Active, medicine, Humans, 030212 general & internal medicine, Darunavir, Retrospective Studies, Ritonavir, Nucleoside analogue, business.industry, virus diseases, General Medicine, Cohort, Hiv patients, Female, Observational study, Once daily, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7daebc9297abc755b21124f7d9c46a94Test
https://doi.org/10.1080/17843286.2018.1458428Test -
6
المؤلفون: Gonzalo Nocea, Ashley E. Davis, Anita Brogan, Bridgett Goodwin, Virginia Lozano
المصدر: HIV Clinical Trials. 18:214-222
مصطلحات موضوعية: Adult, Male, 0301 basic medicine, Oncology, medicine.medical_specialty, Darunavir+Ritonavir, Drug-Related Side Effects and Adverse Reactions, Anti-HIV Agents, 030106 microbiology, Human immunodeficiency virus (HIV), HIV Infections, medicine.disease_cause, Cohort Studies, 03 medical and health sciences, 0302 clinical medicine, Acquired immunodeficiency syndrome (AIDS), Antiretroviral Therapy, Highly Active, Internal medicine, medicine, Humans, Pharmacology (medical), 030212 general & internal medicine, Darunavir, business.industry, medicine.disease, Raltegravir, Atazanavir, Clinical trial, Treatment Outcome, Infectious Diseases, Spain, Costs and Cost Analysis, Female, Ritonavir, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c459bc5baaf4b232380f8a138e57c98Test
https://doi.org/10.1080/15284336.2017.1402144Test -
7
المؤلفون: Angela Colbers, Eline G. Visser, David M. Burger, Clementien L. Vermont, Annemarie M. C. van Rossum, Michiel van der Flier, Sibyl P. M. Geelen, Diane E. T. Bastiaans, Monique Roukens
المساهمون: Pediatrics
المصدر: Pediatric Infectious Disease Journal, 37(10), 1008-1010. Lippincott Williams & Wilkins
Pediatric infectious disease journal, 37(10), 1008-1010. LIPPINCOTT WILLIAMS & WILKINS
Pediatric Infectious Disease Journal, 37(10), 1008. Lippincott Williams and Wilkins
Pediatric Infectious Disease Journal, 37, 10, pp. 1008-1010
Pediatric Infectious Disease Journal, 37, 1008-1010مصطلحات موضوعية: Male, 0301 basic medicine, Microbiology (medical), Pediatrics, medicine.medical_specialty, Darunavir+Ritonavir, 030106 microbiology, lnfectious Diseases and Global Health Radboud Institute for Molecular Life Sciences [Radboudumc 4], HIV Infections, darunavir, once-daily, Drug Administration Schedule, 03 medical and health sciences, 0302 clinical medicine, Pharmacotherapy, Pharmacokinetics, SDG 3 - Good Health and Well-being, children, medicine, Humans, DRUGS, 030212 general & internal medicine, Dosing, Child, Darunavir, Ritonavir, business.industry, Dosing regimen, HIV, HIV Protease Inhibitors, lnfectious Diseases and Global Health Radboud Institute for Health Sciences [Radboudumc 4], Infectious Diseases, Pediatrics, Perinatology and Child Health, HIV-1, Drug Therapy, Combination, Female, Once daily, business, pharmacokinetics, medicine.drug
وصف الملف: image/pdf; application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::efc054586988872739969a3b04ceaef0Test
https://research.rug.nl/en/publications/1e24a682-6490-49f5-9c51-0e69c4e49a25Test -
8
المؤلفون: James H. Stein, Robert L. Murphy, Todd T. Brown, Theodoros Kelesidis, Grace A. McComsey, Otto O. Yang, Heather J. Ribaudo, Carlee Moser, Judith S. Currier, Michael P. Dubé, Jennifer Rothenberg
المصدر: The Journal of Infectious Diseases. 221:2083-2084
مصطلحات موضوعية: Bone mineral, Darunavir+Ritonavir, Tenofovir, business.industry, musculoskeletal, neural, and ocular physiology, Raltegravir, Emtricitabine, Virology, Major Articles and Brief Reports, Infectious Diseases, medicine, Antiretroviral treatment, Immunology and Allergy, business, medicine.drug, Atazanavir/ritonavir
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b422bd7cb0435ff3d339544ae522b392Test
https://doi.org/10.1093/infdis/jiaa027Test -
9
المؤلفون: Fabio Rigo, M. Lanzafame, E. Concia, Emanuela Lattuada, Stefano Nicolè, Giulia Cucchetto
المصدر: Journal of Antimicrobial Chemotherapy. 73:1728-1730
مصطلحات موضوعية: Adult, Male, 0301 basic medicine, Microbiology (medical), medicine.medical_specialty, Darunavir+Ritonavir, Equivalence Trials as Topic, Anti-HIV Agents, Cross-sectional study, 030106 microbiology, MEDLINE, HIV Infections, law.invention, Cohort Studies, 03 medical and health sciences, Non inferiority, Randomized controlled trial, law, Darunavir/ritonavir 600/100 mg, Internal medicine, medicine, Humans, Drug Dosage Calculations, Pharmacology (medical), Darunavir, Pharmacology, Ritonavir, business.industry, Middle Aged, Cross-Sectional Studies, Infectious Diseases, HIV-1, Female, Once daily, business, Cohort study
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2dea411e8282b8ae760d333782119b6dTest
https://doi.org/10.1093/jac/dky086Test -
10
المؤلفون: Rossetti, B., Gagliardini, R., Sterrantino, G., Colangeli, V., Latini, A., Colafigli, M., Vignale, F., Rusconi, S., Di Biagio, A., Orofino, G., Mezzaroma, I., Vullo, V., Francisci, D., Mastroianni, C., Trezzi, M., Canovari, B., Lamonica, S., Ciccullo, A., Borghetti, A., D'Arminio Monforte, A., Di Giambenedetto, S., De Luca, A., GUSTA trial study group
المصدر: Journal of Acquired Immune Deficiency Syndromes (1999)
مصطلحات موضوعية: Oncology, Liver Cirrhosis, Male, medicine.medical_specialty, Darunavir+Ritonavir, Anti-HIV Agents, Liver fibrosis, Antiretroviral Therapy, HIV Infections, Darunavir, Disease Progression, Drug Substitution, Female, HIV-1, Humans, Maraviroc, Middle Aged, Ritonavir, Antiretroviral Therapy, Highly Active, Settore MED/17 - MALATTIE INFETTIVE, law.invention, chemistry.chemical_compound, Randomized controlled trial, law, Internal medicine, medicine, Pharmacology (medical), Highly Active, Dual therapy, Letters to the Editor, business.industry, fibrosis, Disease progression, HIV, Antiretroviral therapy, Infectious Diseases, chemistry, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::960be3bf4667a843383a4514dd83c591Test
https://hdl.handle.net/11567/992013Test